An Open-label, Multicentre Study Comparing the Biological Potency of the Native, Depigmented and Depigmented Polymerized Cat Epithelial Allergenic Extracts.
Phase of Trial: Phase II
Latest Information Update: 08 Jul 2014
At a glance
- Drugs Cat allergy immunotherapy (Primary)
- Indications Allergic asthma; Allergic rhinoconjunctivitis
- Focus Therapeutic Use
- Sponsors Laboratorios LETI
- 21 May 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 09 Jan 2013 New trial record